American Century Companies’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$702K Buy
+2,717
New +$723K ﹤0.01% 2432
2024
Q4
Sell
-1,099
Closed -$200K 2922
2024
Q3
$200K Buy
+1,099
New +$212K ﹤0.01% 2759
2023
Q3
Sell
-2,440
Closed -$286K 2873
2023
Q2
$286K Buy
+2,440
New +$249K ﹤0.01% 2408

Other funds holding KRYS

American Century Companies's KRYS Position: Q1 2026 in Review

American Century Companies opened a new position in Krystal Biotech (KRYS) in Q1 2026: 2,717 shares worth $702K. The stake represents ﹤0.01% of the portfolio and ranks #2432 among its holdings. This is a return to the name: American Century Companies previously reported a position in KRYS as recently as Q3 2024.

American Century Companies first reported a position in KRYS in Q2 2023 and has held it in 3 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • American Century Companies held 2,717 shares of Krystal Biotech worth $702K as of Q1 2026.
  • Krystal Biotech was a new American Century Companies position in Q1 2026.
  • Krystal Biotech made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2432 holding.
  • American Century Companies first reported a position in Krystal Biotech in Q2 2023 and has held it in 3 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.